Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 218-664-7
CAS number: 2212-81-9
The in vitro rate of metabolism was determined for the read across source [1,3(or 1,4)- Phenylenebis(1-methylethylidene)] bis[tert-butyl] peroxide using the in vitro metabolism trout liver S9 assay (OECD Test Guideline 319B).
This organic peroxide metabolized rapidly under biologically active conditions with a metabolic half- life of 67 minutes or 1.13 hours. This data was used to extrapolate in vivo rate constants of metabolism or kMETof 0.184 day-1or 0.475 day-1using hepatic portal blood flow or hepatic portal and arterial blood flow, respectively. The use of these kMET values in conjunction with the Gobas model dropped the calculated BCF from 45,294 kg day-1(assuming no metabolism) to 536 or 209 kg day-1. The impact of metabolism on the read across source [1,3(or 1,4)- Phenylenebis(1-methylethylidene)] bis[tert-butyl] peroxide drops the BCF to less than the action level of 2000 (Reach Criteria) and should not be considered to have significant bioaccumulation potential.
However, following the Echa decision number SEV-D-2114369067-43-01/F, a bioaccumulation in fish study according to the OECD 305 using the aqueous exposure was performed under flow-through conditions on the read across source. The results are based on the time-weighted average as requested in the Echa decision. Based on this, the steady-state BCFss is equal to 1083 L/Kg and the steady-state BCFss normalised to a fish lipid content of 5% is equal to 1635 L/Kg.The lipid noramlised and growth corrected kinetic BCFkLg value is equal to 1820 L/kg.
The Dutch National Health Institute (RIVM) concluded that BCF derivation should be performed differently and derived a BCFSSL (steady-state BCFSS normalised to a fish lipid content of 5%) of 2480 L/kg and a lipid normalised and growth corrected kinetic BCFkLg of 2201 L/kg for 0.579 µg/L (time-weighted average).RIVM also noted that from the results presented it is possible that the 1,4 substituted isomer is more bioaccumulative than the 1,3 substituted isomer.
From these results the registrant believes that it is worthwhile confirming this and proposes to perform a similar BCF study with the single 1,3 substituted isomer (CAS 2212-82-9). A contract lab was already approached to perform this study, but before starting this study the registrant will wait for the results of the P-assessment, the OECD 308 study. When it can be shown that the substance is not persistent an additional OECD 305 is not deemed necessary.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Deze website maakt gebruik van cookies om het surfen zo aangenaam mogelijk te maken.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again